Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

16.56
-0.4400-2.59%
Post-market: 16.52-0.0400-0.24%19:49 EDT
Volume:13.57M
Turnover:227.28M
Market Cap:18.99B
PE:-14.49
High:17.09
Open:17.00
Low:16.56
Close:17.00
Loading ...

Teva Releases Q2 2025 Aide Memoire

THOMSON REUTERS
·
8 hours ago

Teva Pharmaceuticals Is Maintained at Buy by UBS

Dow Jones
·
Yesterday

Leader Capital Markets Remains a Buy on Teva (TEVA)

TIPRANKS
·
21 Jun

Teva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating

TIPRANKS
·
18 Jun

Teva (TEVA) Gets a Buy from Leader Capital Markets

TIPRANKS
·
17 Jun

Teva, Fosun Pharma partner to develop TEV-56278

TIPRANKS
·
16 Jun

Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)

TIPRANKS
·
14 Jun

Teva put volume heavy and directionally bearish

TIPRANKS
·
14 Jun

Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)

TIPRANKS
·
10 Jun

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Johnson & Johnson (JNJ) and Design Therapeutics (DSGN)

TIPRANKS
·
09 Jun

Leader Capital Markets Sticks to Its Buy Rating for Teva (TEVA)

TIPRANKS
·
07 Jun

Teva Pharmaceuticals Initiated at Buy by Goldman Sachs

Dow Jones
·
06 Jun

Teva initiated with a Buy at Goldman Sachs

TIPRANKS
·
06 Jun

Teva Pharmaceutical Industries Raises Pool Tender Offer, Reports Early Tender Results

MT Newswires Live
·
03 Jun

Teva announces results from a study of treatment patterns of tardive dyskinesia

TIPRANKS
·
02 Jun

Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts

TIPRANKS
·
31 May

New Data From Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

THOMSON REUTERS
·
31 May

Teva Pharmaceutical (TEVA) Receives a Buy from UBS

TIPRANKS
·
30 May

Teva reaffirms ‘Pivot to Growth’ strategy with launch of acceleration phase

TIPRANKS
·
29 May

Teva Reaffirms “Pivot to Growth” Strategy Progress With Launch of Acceleration Phase at 2025 Innovation and Strategy Day

THOMSON REUTERS
·
29 May